Comparison

SARS-CoV SSp-1 A2 (HLA-A*02:01) European Partner

€184.00
Excl. VAT
Item no. EP14587_5
Manufacturer peptides & elephants
Amount 5 mg
Category
Type Peptides
Applications FC
Specific against SARS-CoV-2
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias RLNEVAKNL HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Available
Description
The sequence is related to the HLA-A*0201-restricted coronavirus SARS-CoV spike protein peptide SSp-1.

It was demonstrated that SARS-CoV protein-derived peptide-1 (SSp-1 RLNEVAKNL) induces peptide-specific CTLs both in vivo (transgenic mice) and in vitro (human PBLs), which specifically releases interferon-gamma (IFN-gamma) upon stimulation with SSp-1-pulsed autologous dendritic cells (DCs) or T2 cells.
Keywords
RLNEVAKNL HLA-A*02:01 Coronavirus(COVID-19) Flow Cytometry
Sequence
RLNEVAKNL
N-Terminus
H
C-Terminus
OH
Purity
0, 95
Counter-Ion
TFA
Allele
HLA-A*02:01
Application
Flow Cytometry
Indication
Coronavirus(COVID-19)
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €184.00
Price: €184.00
available

Delivery expected until 9/18/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close